India: Medesole signs IVF deal with INVO Bioscience

Medesole, a supplier of healthcare products in India and the Middle East, has signed an agreement with medical device company INVO Bioscience to operate dedicated INVOcell clinics in India. “Over the past year, we have spent significant time evaluating potential partners to enter the rapidly growing Indian market,” said Steve Shum, chief executive of INVO…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »